SCHEMBL2322334

SCHEMBL2322334

COCOc1ccccc1OC(F)(F)F

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RXRA P19793 1/20 0.46
RXRB P28702 1/20 0.46
RXRG P48443 1/20 0.46
L3MBTL1 Q9Y468 2/20 0.39
ALDH1A1 P00352 1/20 0.39
SSTR1 P30872 1/20 0.39
SSTR4 P31391 1/20 0.39
SLC6A3 Q01959 2/20 0.37
SLC6A2 P23975 1/20 0.37
SLC6A4 P31645 1/20 0.37
SCN9A Q15858 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
KCNK3 O14649 1/20 0.36
KCNK9 Q9NPC2 1/20 0.36
HSD11B1 P28845 1/20 0.36
FFAR4 Q5NUL3 1/20 0.35
KCNN4 O15554 1/20 0.35
VNN1 O95497 1/20 0.35
PTPN1 P18031 1/20 0.35
GRIN2B Q13224 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29860268 1.00 RXRA (0.46) RXRARXRBRXRGL3MBTL1ALDH1A1
SCHEMBL30741239 0.83 CA12 (0.48) L3MBTL1ALDH1A1TDP1KCNN4PTPN1
SCHEMBL3185351 0.83 CA12 (0.48) L3MBTL1ALDH1A1TDP1KCNN4PTPN1
SCHEMBL30741241 0.83 CA12 (0.48) L3MBTL1ALDH1A1TDP1KCNN4PTPN1
SCHEMBL3719912 0.82 CLCN2 (0.36) RXRARXRBRXRGL3MBTL1ALDH1A1
SCHEMBL18190386 0.82 PTPN1 (0.35) RXRARXRBRXRGL3MBTL1ALDH1A1
SCHEMBL29155199 0.81 RXRA (0.44) RXRARXRBRXRGL3MBTL1ALDH1A1
SCHEMBL10030738 0.81 L3MBTL1 (0.41) L3MBTL1ALDH1A1SLC6A2SLC6A4SCN9A
SCHEMBL3710628 0.80 RXRA (0.35) RXRARXRBRXRGL3MBTL1ALDH1A1
SCHEMBL29122166 0.79 BACE1 (0.36) RXRARXRBRXRGL3MBTL1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240140965-A1 TRICYCLIC PESTICIDAL COMPOUNDS BASF SE (DE) 2024-05-02 US disclosed
EP-4305042-A1 TRICYCLIC PESTICIDAL COMPOUNDS BASF SE (DE) 2024-01-17 EP disclosed
CN-116964062-A Pesticidal tricyclic compounds 巴斯夫欧洲公司 2023-10-27 CN disclosed
WO-2022189191-A1 TRICYCLIC PESTICIDAL COMPOUNDS BASF SE (DE) 2022-09-15 WO disclosed
EP-2484669-B1 PHENOL DERIVATIVES FUJI YAKUHIN CO LTD (JP) 2015-07-29 EP disclosed
CN-102639518-B Novel Phenol Derivatives FUJI YAKUHIN CO LTD 2015-03-25 CN disclosed
US-8859584-B2 TRPV1 antagonists ABBVIE, INC. (US) 2014-10-14 US disclosed
US-8609692-B2 TRPV1 antagonists ABBVIE INC. (US) 2013-12-17 US disclosed
US-8604053-B2 TRPV1 antagonists ABBVIE INC. (US) 2013-12-10 US disclosed
WO-2013096223-A1 TRPV1 ANTAGONISTS ABBVIE INC. (US) 2013-06-27 WO disclosed
EP-2352726-A1 TRPV1 ANTAGONISTS Abbott Laboratories (US) 2011-08-10 EP disclosed
EP-2352727-A1 TRPV1 ANTAGONISTS Abbott Laboratories (US) 2011-08-10 EP disclosed
CN-101827585-A Solid dispersion product containing N-aryl ureido compound ABBOTT GMBH & CO KG 2010-09-08 CN disclosed
EP-2197426-A2 SOLID DISPERSION PRODUCT CONTAINING N-ARYL UREA-BASED COMPOUND Abbott GmbH & Co. KG (DE) 2010-06-23 EP disclosed
US-20100137360-A1 TRPV1 ANTAGONISTS ABBOTT LABORATORIES (US) 2010-06-03 US disclosed
US-20100120846-A1 TRPV1 ANTAGONISTS ABBOTT LABORATORIES (US) 2010-05-13 US disclosed
WO-2010045402-A1 TRPV1 ANTAGONISTS ABBOTT LABORATORIES (US) 2010-04-22 WO disclosed
WO-2010045401-A1 TRPV1 ANTAGONISTS ABBOTT LABORATORIES (US) 2010-04-22 WO disclosed
US-20090143423-A1 SOLID DISPERSION PRODUCT CONTAINING N-ARYL UREA-BASED COMPOUND ABBOTT GMBH & CO. KG (DE) 2009-06-04 US disclosed
WO-2009050289-A2 SOLID DISPERSION PRODUCT CONTAINING N-ARYL UREA-BASED COMPOUND ABBOTT GMBH & CO. KG (DE) 2009-04-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100137360-A1 TRPV1 ANTAGONISTS TRPV1, TRPV3, TRPV2 RXRA 494/4885RXRB 500/4885RXRG 453/4885
US-20100120846-A1 TRPV1 ANTAGONISTS TRPV1, TRPV3, TRPV2 RXRA 477/4885RXRB 478/4885RXRG 420/4885
US-20240140965-A1 TRICYCLIC PESTICIDAL COMPOUNDS DDT, ACHE, PFAS RXRA 4469/4885RXRB 4628/4885RXRG 4328/4885
US-20090143423-A1 SOLID DISPERSION PRODUCT CONTAINING N-ARYL UREA-BASED COMPOUND U2SURP, UMPS, HNRNPUL1 RXRA 1571/4885RXRB 1290/4885RXRG 1692/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.